The process of inflammation driven intestinal repair is known to promote a tumour-promoting environment [24, 28], and the release of HMGB1 contributes to tumourigenesis in mouse models of colitis-associated cancer [24, 25, 29]. Here, HMGB1 is linked to neoplasm.